Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 1579

Biochemistry & Physiology: Open Access received 1579 citations as per Google Scholar report

Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • Ulrich's Periodicals Directory
  • Electronic Journals Library
  • RefSeek
  • Directory of Research Journal Indexing (DRJI)
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Scholarsteer
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Euro Pub
  • ICMJE
Share This Page

Zhou J. Deng

Massachusetts Institute of Technology

Biography

Dr. Jason Deng is an Early Career Research Fellow awarded by the National Health and Medical Research Council, Australia in 2013. Since 2011, Jason has joined Massachusetts Institute of Technology as a postdoctoral researcher, working with Professor Paula Hammond at Koch Institute for Integrative Cancer Research. Jason received his PhD in biomedical sciences at the University of Queensland, Australia in 2011with distinction of Dean’s award in research excellence.

Research Interest

Jason’s research has been focusing on the interdisciplinary field of Nano-Biosciences: investigating the interactions of nanomaterials with biological systems, developing new type of cancer therapeutics using nanotechnology, and promoting translation of benchtop research to bedside medicine. His work involves nanomedicine, drug and siRNA delivery, combination therapeutics development, nanotoxicology, cell-based assay development for drug discovery, biomarker discovery and cancer diagnostics. Jason published as the first author in prestigious journals such as Nature Nanotechnology, ACS Nano, and Nanotoxicology; while his collaborative work has been published in Lancet, Advanced Materials, Advanced Healthcare Materials and Scientific Reports.

Certificate

Certificate

Global Speakers in the subject

Global Experts in the subject

Relevant Topics
Top